Business Description
Jupiter Life Line Hospitals Ltd
ISIN : INE682M01012
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.9 | |||||
Interest Coverage | 464.9 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 44.72 | |||||
Beneish M-Score | -1.26 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 32.8 | |||||
3-Year EBITDA Growth Rate | 63.2 | |||||
3-Year Book Growth Rate | 69.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 16.41 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.05 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.74 | |||||
9-Day RSI | 56.05 | |||||
14-Day RSI | 58.57 | |||||
6-1 Month Momentum % | 17.25 | |||||
12-1 Month Momentum % | 28.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.34 | |||||
Quick Ratio | 3.15 | |||||
Cash Ratio | 2.56 | |||||
Days Inventory | 34.11 | |||||
Days Sales Outstanding | 18.05 | |||||
Days Payable | 87.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.07 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.07 | |||||
5-Year Yield-on-Cost % | 0.07 | |||||
Shareholder Yield % | 0.07 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.91 | |||||
Operating Margin % | 18.67 | |||||
Net Margin % | 15.78 | |||||
FCF Margin % | 2.49 | |||||
ROE % | 15.82 | |||||
ROA % | 14.23 | |||||
ROIC % | 17.35 | |||||
ROC (Joel Greenblatt) % | 30.88 | |||||
ROCE % | 21.26 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 54.07 | |||||
Forward PE Ratio | 46.66 | |||||
PE Ratio without NRI | 54.21 | |||||
PS Ratio | 8.49 | |||||
PB Ratio | 7.81 | |||||
Price-to-Tangible-Book | 7.82 | |||||
Price-to-Free-Cash-Flow | 315.61 | |||||
Price-to-Operating-Cash-Flow | 80.56 | |||||
EV-to-EBIT | 38.01 | |||||
EV-to-EBITDA | 32.06 | |||||
EV-to-Revenue | 8.1 | |||||
EV-to-FCF | 322.93 | |||||
Price-to-Graham-Number | 4.34 | |||||
Price-to-Net-Current-Asset-Value | 33.43 | |||||
Price-to-Net-Cash | 50.89 | |||||
Earnings Yield (Greenblatt) % | 2.64 | |||||
FCF Yield % | 0.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jupiter Life Line Hospitals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 11,728.05 | ||
EPS (TTM) (₹) | 27.71 | ||
Beta | 0 | ||
Volatility % | 35.48 | ||
14-Day RSI | 58.57 | ||
14-Day ATR (₹) | 56.743254 | ||
20-Day SMA (₹) | 1455.4675 | ||
12-1 Month Momentum % | 28.73 | ||
52-Week Range (₹) | 1037.4 - 1648.6 | ||
Shares Outstanding (Mil) | 65.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jupiter Life Line Hospitals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jupiter Life Line Hospitals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Jupiter Life Line Hospitals Ltd Frequently Asked Questions
What is Jupiter Life Line Hospitals Ltd(BOM:543980)'s stock price today?
When is next earnings date of Jupiter Life Line Hospitals Ltd(BOM:543980)?
Does Jupiter Life Line Hospitals Ltd(BOM:543980) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |